Skip to Main Content

Paper Details

Third and Fourth Vaccine Doses Broaden and Prolong Immunity to SARS-CoV-2 in Adult Patients with Immune-Mediated Inflammatory Diseases.
J Immunol
8
2023
BA, IFN, IL-2, IL-4, IMID, IMIDs, Immune-Mediated Inflammatory Diseases, Omicron BA, PBMCs, Patients, SARS, SARS-, SARS-CoV, SARS-CoV-2, SARS-CoV-2 mRNA, T cell, TNF, ankylosing spondylitis, anti-TNF, immune-mediated inflammatory diseases, inflammatory bowel disease, mRNA-1273, patients, psoriasis, psoriatic arthritis, rheumatoid arthritis, wild
Author NameAffiliation
Mark S SilverbergLunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital
Mark S SilverbergUniversity of Toronto
Mark S SilverbergMount Sinai Hospital
Anne-Claude GingrasLunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital
Anne-Claude GingrasUniversity of Toronto
  • 1 - 5

Datasets

Release 1.2